Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C, Crisafulli C, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A.
Fabbri C, et al. Among authors: crisafulli c.
Eur Arch Psychiatry Clin Neurosci. 2017 Dec;267(8):723-735. doi: 10.1007/s00406-017-0766-1. Epub 2017 Mar 4.
Eur Arch Psychiatry Clin Neurosci. 2017.
PMID: 28260126
Clinical Trial.